• Lantheus Alpha Therapy, a 10% owner, cut its stake in Perspective Therapeutics through open-market sales on Sept. 3-4, 2026.
• Sold 247,932 common shares at weighted-average prices of $3.11 and $3.15.
• Beneficial ownership fell to 11,273,364 shares from 11,521,296 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perspective Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002064832-26-000318), on September 08, 2026, and is solely responsible for the information contained therein.